One Biosciences
ID: 14412612AI-driven single cell transcriptomic oncology platform to guide treatment decisions, patient selection, therapy development, and optimize clinical trials.
1
Funding Rounds
$17.5m
Money raised
Recent Funding Rounds
Overview
AI-driven single cell transcriptomic oncology platform to guide treatment decisions, patient selection, therapy development, and optimize clinical trials.
- Website:
- Business model: B2B
- Headquarters: Paris
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma**** Ri***** |
|
- | |
| Da*** Sc******** |
|
- | |
| Ce**** Va**** |
|
- |
Funding series
Funding Series Analysis
The company One Biosciences has raised a total of $17.5m in funding over 1 rounds.
Key Insights:
- One Biosciences Series A Round, July 2025: $17.5m
Industries
One Biosciences is active in the following industries: